Skip to Main Content

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Conditions

HIV/AIDS

Phase III

What is the purpose of this trial?

Brief Summary:

The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.

  • Trial with
    ViiV Healthcare Company
  • Start Date
    02/27/2018
  • End Date
    08/17/2016
Trial Image

For more information about this study, contact:

Laurie Andrews

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/15/2019
  • Study HIC
    #2000023674